You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華康生物醫學(08622.HK)擬聯手春雷生物組香港合資 拓展男性生育市場
格隆匯 04-08 16:46

格隆匯4月8日丨華康生物醫學(08622.HK)宣佈,公司的直接全資子公司華康香港於2020年4月8日與春雷生物簽訂了諒解備忘錄,內容有關可能於香港成立一間合資公司,(i)以微流控技術和即時檢驗生物醫學測試的使用及應用於診斷男性生育能力的相關研發;及(ii)商業化若干男性生育能力市場的微流控診斷產品。除若干條款(包括盡職調查,有效期和排他性,保密性以及適用法律和司法管轄權)外,諒解備忘錄不具有法律約束力。

據悉,擬議中的合資公司股東持股比例分別為華康香港55%及春雷生物45%。

這是集團開發新產品和改善現有產品之策略的一部分。就此而言,董事認為這是與春雷生物合作的好機會,以便在彼此各自的專業領域結合並利用彼此的知識產權、技術知識和資源,即(i)集團的男性生育領域;及(ii)春雷生物的微流控技術和分子診斷領域。因此,預計通過各方知識產權、技術知識和資源的彙集將產生有價值的協同作用。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account